drugset / Trial / NCT00853840

Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc

NCT00853840

Phase 4 Completed 18 enrolled ViiV Healthcare Pfizer · collab
RandomizedCrossoverSingle-blindTreatment

Summary

The objective of this study was to estimate the effects of a single dose of vardenafil on the blood pressure (BP) in subjects receiving maraviroc (MVC) (dosed to steady-state) and to assess the safety and tolerability of MVC in subjects receiving a single dose of vardenafil.

Timeline

Start
2008-04
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Maraviroc Other / unclassified 300 mg
Subject Vardenafil Small molecule 20 mg Oral

Indications